In summary, our study has revealed that miR-181c upregulation plays an important role in pancreatic cancer progression and miR-181c is a critical repressor of Hippo signaling by targeting the core kinase cassette, i.e., MST1, LATS2, SAV1 and MOB1. Here, LATS2 is linked to pancreatic neoplasm.